21
Participants
Start Date
May 31, 2007
Primary Completion Date
November 30, 2010
Study Completion Date
October 31, 2013
Avastin
Avastin will be administered intravenously (vein) at 10mg/kg every two weeks starting day 1 for a total of 3 doses.
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Genentech, Inc.
INDUSTRY
Brigham and Women's Hospital
OTHER
Beth Israel Deaconess Medical Center
OTHER
Massachusetts General Hospital
OTHER
Lowell General Hospital
OTHER
Saint Anne's Hospital
OTHER
Dana-Farber Cancer Institute
OTHER